Pilar Meagan, Elwy A Rani, Lushniak Larissa, Huang Grace, McLoughlin Gabriella M, Hooley Cole, Nadesan-Reddy Nisha, Sandler Brittney, Moshabela Mosa, Alonge Olakunle, Geng Elvin, Proctor Enola
Department of Infectious Diseases, Washington University School of Medicine, Washington University in St. Louis, St. Louis, MO, United States.
Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, RI, United States.
Front Health Serv. 2022 May 20;2:897227. doi: 10.3389/frhs.2022.897227. eCollection 2022.
Recent articles have highlighted the importance of incorporating implementation science concepts into pandemic-related research. However, limited research has been documented to date regarding implementation outcomes that may be unique to COVID-19 vaccinations and how to utilize implementation strategies to address vaccine program-related implementation challenges. To address these gaps, we formed a global COVID-19 implementation workgroup of implementation scientists who met weekly for over a year to review the available literature and learn about ongoing research during the pandemic. We developed a hierarchy to prioritize the applicability of "lessons learned" from the vaccination-related implementation literature. We identified applications of existing implementation outcomes as well as identified additional implementation outcomes. We also mapped implementation strategies to those outcomes. Our efforts provide rationale for the utility of using implementation outcomes in pandemic-related research. Furthermore, we identified three additional implementation outcomes: availability, health equity, and scale-up. Results include a list of COVID-19 relevant implementation strategies mapped to the implementation outcomes.
近期的文章强调了将实施科学概念纳入与大流行相关研究的重要性。然而,迄今为止,关于COVID-19疫苗接种可能特有的实施结果以及如何利用实施策略来应对与疫苗计划相关的实施挑战的研究记录有限。为了填补这些空白,我们组建了一个全球COVID-19实施工作组,由实施科学家组成,他们在一年多的时间里每周开会,以审查现有文献并了解大流行期间正在进行的研究。我们制定了一个层级体系,以确定疫苗接种相关实施文献中“经验教训”的适用性优先级。我们确定了现有实施结果的应用,并确定了其他实施结果。我们还将实施策略与这些结果进行了映射。我们的努力为在与大流行相关的研究中使用实施结果的效用提供了理论依据。此外,我们确定了另外三个实施结果:可及性、健康公平和扩大规模。结果包括一份与COVID-19相关的实施策略清单,这些策略与实施结果相对应。